Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,26 € ↑0,09 (1,74%)
2026-06-05
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionGeode Capital Management, Llc
Latest Disclosed Ownership1,442,965 shares
Latest Disclosed Value $ 9,973,228
Geode Capital Management, Llc reports 3.68% increase in ownership of VM4 / Vanda Pharmaceuticals Inc.

On May 15, 2026 - Geode Capital Management, Llc filed a 13F-HR form disclosing ownership of 1,442,965 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $8,297,049 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 1,391,790 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of 3.68% during the quarter. The current value of the position is $7,589,996 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,442,965 51,175 3.68 9,973 -18.77 0.0003
2026-02-09 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,391,790 -295 -0.02 12,278 76.71 0.0008
2025-11-12 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,392,085 -299,553 -17.71 6,948 -13.00 0.0004
2025-08-08 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,691,638 77,997 4.83 7,986 7.80 0.0006
2025-05-13 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,613,641 163,331 11.26 7,408 6.62 0.0006
2025-02-12 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,450,310 24,483 1.72 6,949 3.89 0.0005
2024-11-12 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,425,827 94,870 7.13 6,689 -11.08 0.0005
2024-08-09 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,330,957 85,575 6.87 7,522 46.92 0.0007
2024-05-13 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,245,382 -121 -0.01 5,119 -2.61 0.0005
2024-02-13 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,245,503 66,248 5.62 5,257 3.16 0.0005
2023-11-13 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,179,255 44,331 3.91 5,095 -31.88 0.0006
2023-08-11 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,134,924 52,393 4.84 7,479 1.76 0.0009
2023-05-15 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,082,531 29,941 2.84 7,350 104,900.00 0.0010
2023-02-13 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,052,590 26,077 2.54 8 -99.93 0.0011
2022-11-14 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,026,513 9,345 0.92 10,141 -8.53 0.0015
2022-08-12 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,017,168 4,727 0.47 11,087 -3.17 0.0016
2022-05-13 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,012,441 -14,817 -1.44 11,450 -28.96 0.0014
2022-02-11 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 1,027,258 16,554 1.64 16,117 -6.96 0.0019
2021-11-12 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,010,704 6,342 0.63 17,323 -19.81 0.0023
2021-08-13 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 1,004,362 38,948 4.03 21,603 48.99 0.0030
2021-05-12 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 965,414 113,991 13.39 14,500 29.61 0.0022
2021-02-12 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 851,423 33,581 4.11 11,187 41.61 0.0019
2020-11-13 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 817,842 11,924 1.48 7,900 -14.31 0.0015
2020-08-13 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 805,918 43,693 5.73 9,219 16.76 0.0020
2020-05-14 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 762,225 1,663 0.22 7,896 -36.73 0.0021
2020-02-20 2019-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 760,562 3,323 0.44 12,480 24.12 0.0026
2020-02-13 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 760,562 3,323 12,480 1,590.4666
2019-11-12 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 757,239 29,354 4.03 10,055 -1.95 0.0023
2019-08-14 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 727,885 88,791 13.89 10,255 -12.79 0.0025
2019-05-14 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 639,094 42,468 7.12 11,759 -24.56 0.0030
2019-03-06 2018-12-31 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 596,626 6,666 1.13 15,588 15.13 0.0048
2019-02-13 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 596,626 6,666 15,588
2018-11-13 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 589,960 25,040 4.43 13,539 25.82 0.0038
2018-08-14 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 564,920 63,774 12.73 10,761 27.45 0.0033
2018-05-15 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 501,146 102,100 25.59 8,443 39.21 0.0028
2018-02-13 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 399,046 -26,998 -6.34 6,065 -20.46 0.0021
2017-11-14 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 426,044 -6,010 -1.39 7,625 8.28 0.0028
2017-08-14 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 432,054 19,530 4.73 7,042 21.94 0.0028
2017-06-21 2017-03-31 13F/A-1 VANDA PHARMACTCLS COM 921659108 412,524 23,941 6.16 5,775 -6.81 0.0024
2017-05-12 2017-03-31 13F VANDA PHARMACTCLS COM 921659108 412,524 5,775
2017-02-14 2016-12-31 13F VANDA PHARMACTCLS COM 921659108 388,583 16,274 4.37 6,197 0.03 0.0029
2016-11-10 2016-09-30 13F VANDA PHARMACTCLS COM 921659108 372,309 4,652 1.27 6,195 50.58 0.0031
2016-08-12 2016-06-30 13F VANDA PHARMACTCLS COM 921659108 367,657 -12,014 -3.16 4,114 29.66 0.0022
2016-05-13 2016-03-31 13F VANDA PHARMACTCLS COM 921659108 379,671 31,939 9.18 3,173 -1.98 0.0017
2016-02-12 2015-12-31 13F VANDA PHARMACTCLS COM 921659108 347,732 66,261 23.54 3,237 1.98 0.0018
2015-11-13 2015-09-30 13F VANDA PHARMACTCLS COM 921659108 281,471 -14,074 -4.76 3,174 -15.36 0.0019
2015-08-14 2015-06-30 13F VANDA PHARMACTCLS COM 921659108 295,545 71,473 31.90 3,750 80.03 0.0021
2015-05-14 2015-03-31 13F VANDA PHARMACTCLS COM 921659108 224,072 2,967 1.34 2,083 -34.21 0.0012
2015-02-12 2014-12-31 13F VANDA PHARMACTCLS COM 921659108 221,105 27,365 14.12 3,166 57.43 0.0019
2014-11-14 2014-09-30 13F VANDA PHARMACTCLS COM 921659108 193,740 2,248 1.17 2,011 -35.09 0.0013
2014-08-13 2014-06-30 13F VANDA PHARMACTCLS COM 921659108 191,492 1,563 0.82 3,098 0.39 0.0020
2014-05-14 2014-03-31 13F VANDA PHARMACTCLS COM 921659108 189,929 5,113 2.77 3,086 34.58 0.0021
2014-02-14 2013-12-31 13F VANDA PHARMACTCLS COM 921659108 184,816 4,751 2.64 2,293 16.10 0.0016
2013-11-14 2013-09-30 13F VANDA PHARMACTCLS COM 921659108 180,065 7,362 4.26 1,975 41.58 0.0016
2013-08-14 2013-06-30 13F VANDA PHARMACTCLS COM 921659108 172,703 172,703 1,395 0.0012
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.